Sera Prognostics

Company SERA

Last mentioned: Mar 19, 2026

Timeline

  1. Phase 1 Deployment

    Target date for first 150MW of Oklo-Meta power campus to go online.

  2. Runway Horizon

    Current capital projected to fund operations through significant commercial milestones.

  3. Cash Runway Limit

    Current capital projected to fund operations through this period across commercial milestones.

  4. 2026 Target

    Goal to reach 15-17 states and operate 5-7 live partner programs.

  5. Commercial Target

    Goal to reach 15-17 states and 5-7 live partner programs.

  6. Q4 Earnings Call

    Management outlines pivot from R&D to commercial scaling and state-level engagement.

  7. Q4 Earnings Call

    Management confirms runway through 2028 and details PRIME study impact.

  8. Sera Prognostics Commercial Pivot

    Announces target to reach 15-17 states and 60% of US births by year-end.

  9. Meta-Oklo Agreement

    Execution of 1.2GW Aurora power campus development in Ohio.

  10. Meta-Oklo Agreement

    Execution of prepayment agreement for 1.2GW Aurora power campus in Ohio announced.

  11. Ecopetrol Dividend Proposal

    Board proposes COP 110 per share dividend representing 50% of net income.

  12. Ecopetrol Dividend

    Board proposes COP 110 per share dividend following strong operational cash flow.

  13. Oklo Capital Raise

    Raises $1.182 billion net through ATM program to fund Aurora projects.

  14. Oklo Capital Raise

    Oklo raises $1.182B net through a $1.5B ATM program to fund SMR construction.

  15. Fiscal Year End

    Sera concludes 2025 with $95.8M cash and successful PRIME study publication.

  16. Fiscal Year End

    Sera concludes 2025 with $95.8M in cash and a narrowed net loss.

  17. Year-End Financials

    Oklo reports $1.4B in cash; IZEA reaches breakeven; Sera Prognostics completes PRIME study.

  18. Ecopetrol Production Peak

    Reports highest production in a decade at 751,000 boe/d.

Stories mentioning Sera Prognostics 7

earnings Bullish

AI Infrastructure and Specialized SaaS Pivot Toward Profitability and Scale

The Q4 2025 earnings cycle reveals a strategic shift among specialized technology and infrastructure providers toward long-term scalability and operational discipline. While Oklo secures massive energy commitments from Meta to power the AI revolution, SaaS players like IZEA and Sera Prognostics are prioritizing high-value enterprise accounts and clinical data validation to navigate a tightening macroeconomic environment.

6 sources
market-trends Bullish

Strategic Endurance: Q4 Earnings Reveal a New Era for Venture-Scale Publics

The Q4 2025 earnings cycle highlights a critical shift for growth-stage public companies, where massive capital reserves and operational efficiency are being prioritized over immediate revenue. From Oklo's multi-billion dollar infrastructure plays to Sera Prognostics' clinical-milestone focus, the 'Strategic Endurance' model is now the primary driver of market sentiment.

6 sources
earnings Bullish

Q4 Earnings: Tech-Infra and Biotech Pivot as Retail Faces Margin Pressure

The Q4 2025 earnings cycle reveals a stark divergence between high-growth infrastructure bets and established retail and energy players navigating macroeconomic headwinds. While nuclear energy and biotech firms are securing massive capital for long-term deployments, consumer-facing giants like lululemon are grappling with regional stagnation and tariff-driven margin compression.

6 sources
pharma Bullish

Sera Prognostics Leverages PRIME Study Success for 2028 Commercial Runway

Sera Prognostics reported a narrowed annual net loss of $31.9 million for 2025, supported by a robust $95.8 million cash position that extends its operational runway into 2028. The company is pivoting toward large-scale commercialization of its PreTRM test following landmark PRIME study data showing a 56% reduction in very early preterm births.

6 sources
earnings Bullish

Retail Resilience Tested by Tariff Headwinds and Creator Economy Shifts

The Q4 2025 earnings cycle reveals a stark divide in the retail landscape, as lululemon grapples with significant tariff-driven margin compression while IZEA achieves a historic profitability milestone. Simultaneously, Meta’s massive 1.2-gigawatt nuclear agreement with Oklo signals a new era of infrastructure-heavy social commerce.

6 sources
medical-devices Bullish

Sera Prognostics Targets 2028 Runway as PRIME Study Bolsters Commercial Pivot

Sera Prognostics reported a narrowed annual net loss of $31.9 million for 2025, supported by a robust $95.8 million cash position that extends its operational runway into 2028. Following the successful publication of its PRIME study—which demonstrated a 56% reduction in very preterm births—the company is aggressively shifting its focus toward state-level payer engagement and commercial scaling.

6 sources
adtech Bullish

AdTech Efficiency and Big Tech Infrastructure Define Q4 2025 Earnings

The Q4 2025 earnings cycle reveals a strategic shift toward enterprise-scale profitability in AdTech and massive infrastructure investments by Big Tech to fuel AI growth. IZEA achieved its first breakeven year through portfolio rationalization, while Meta secured a landmark 1.2-gigawatt power agreement to support its future advertising engines.

6 sources